York - A Vital Tool for Prostate Cancer Primary Cell Analysis
Life has changed a lot over the past four decades, but for most cancer research centers, studies carried out on cell lines first obtained 40 years ago are commonplace. Things are different in Professor Norman Maitland’s laboratory at the University of York, where the research is carried out on tumor samples obtained regularly in cooperation with local hospitals. Learn more about Dr Fiona Frame and Dr Amanda Noble's prostate cancer research, highlighting how technological advances are enabling scientists to establish which cell types are the most resistant to existing cancer treatments.
St Georges - Automated Live-Cell Tracking streamlines workflows
Greg Perry is Image Resource Facility Microscopy Manager at St George’s University of London, where a Phasefocus Livecyte was installed earlier this year.
Huntsman Cancer Institute - The Plasticity of Melanocytes During the Development of Melanoma
The research group led by Dr Robert Judson-Torres used Livecyte to disprove a long held theory about how stable nevus melanocytes switch to cancerous melanoma cells.
The Francis Crick Institute - The role of HECTD2 Ubiquitin Ligase in Melanoma Progression
Ottina et al. based at the Francis Crick Institute used Livecyte to understand how HECTD2 dysregulation impacts the cell cycle in melanoma.
The Francis Crick Institute - Quantifying Live-Cell Drug Resistance
In this video Dr. Kurt Anderson, Head of Light and Imaging Analysis, and Dr. Alix Le Marois, project research scientist, from The Francis Crick Institute, discuss the numerous techniques and innovations of the Livecyte cell analysis system from Phasefocus. Le Marois’s research models rare populations of cells resistance to lung cancer treatments. This has led to observations of unexpected cell behaviour via the general health and morphology of the cell as enabled by the Livecyte system.